Moreover, MAML2 rearrangement is seen consistently in MECs from various anatomical sites and in a broadly similar proportion of MEC cases, suggesting that MECs of various sites may be considered as one entity. This evidence concerns the gene MAML2 and mucoepidermoid carcinoma.